Interleukin-1α and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3299-3303

  Andersen, Kristin ^a   Mælandsmo, Gunhild Mari ^b   Hovig, Eivind ^b   Fodstad, Øystein ^b   Loennechen, Thrina ^a   Winberg, Jan Olof ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokines; Matrix metalloproteinase inhibitors; Matrix metolloproteinases; Metastasis; S100A4

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CALCIUM BINDING PROTEIN; COLLAGENASE; GELATINASE B; INTERLEUKIN 1ALPHA; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; METASTASIS ASSOCIATED PROTEIN; RIBOZYME; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

BONE NEOPLASMS; COLLAGENASES; ENZYME INDUCTION; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OSTEOSARCOMA; S100 PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED;

EID: 0031730644     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 51: 5054s-5059s, 1991.
2. Crawford HC and Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14: 234-245, 1994.
3. MacDougall JR and Matrisian LM: Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 14: 351-362, 1995.
4. Birkedal-Hansen H, Moore WG, Bodden, MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, and Engler JA: Matrix metallopro-teinases: A review Crit Rev Oral Biol Med 4: 197-250, 1993.
5. Murphy G and Reynolds JJ: Extracellular matrix degradation. In: Connective Tissue and Its Heritable Disorders (Royce MP and Steinman B, eds.). Wiley-Liss, Inc. New York, 1993, pp 287-316.
6. Coussens LM and Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895-904, 1996.
7. Ries C and Petrides PE: Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe Seyler 376: 345-355, 1995.
8. Sherbet GV and Lakshmi MS: The genetics of cancer: genes associated with cancer invasion, metastasis and cell proliferation. Academic Press, London, 1997.
9. 2+ binding protein family. Genes Dev 3: 1086-1093, 1989.
10. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev GP and Lukanidin EM: The mtsl gene and control of tumor metastasis. Gene 135: 229-238, 1993.
11. Takenaga K, Nakamura Y, and Sakiyama S: Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene 14: 331-337, 1997.
12. Davies BR, Davies MP, Gibbs FE, Barraclough R and Rudland PS: Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008, 1993.
13. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Florenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ and Fodstad Ø: Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mtsl) ribozyme. Cancer Res 56: 5490-5498, 1996.
14. 2+-binding proteins of the S100 family in malignant human breast cancer cell lines and biopsy samples. Int J Cancer 57: 684-690, 1994.
15. Merzak A, Parker C, Koochekpour S, Sherbet GV and Pilkington GJ: Overexpression of the 18A2/mts 1 gene and down regulation of the TIMP-2 gene in invasive human glioma cell lines in vitro. Neuropathol Appl Neurobiol 20: 614-619, 1994.
16. Fodstad Ø, Brøgger A, Bruland Ø, Solheim OP, Nesland JM and Pihl A: Characterisics of a cell line established from a patient with multiple osteosarcoma, appearing in 13 years after treatment for bilateral retinoblastoma. Int J Cancer 38: 33-40, 1986.
17. Winberg JO, Anton-Lamrecht I, König A, Bruckner-Tuderman L, Nilssen Ø and Gedde-Dahl TJ: Biochemical, molecular and ultrastructural heterogeneity in severe mutilating recessive dystrophic epidermolysis bullosa. European Journal of Dermatology 4: 463-470, 1994.
18. Svendsrud DH, Loennechen T and Winberg JO: Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasats. Biochem. Pharmacol. 53: 1511-1520, 1997.
19. Solan JL, Deftos LJ, Goding JW and Terkeltaub RA: Expression of the nucleoside triphosphate pyrophosphosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells. J Bone Miner Res 11: 183-192, 1996.
20. Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL and Clayman GL: Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 64: 117-123, 1995.
21. Hurley MM, Marcello K, Abreu C, Brinckerhoff CE, Bowik CC and Hibbs MS: Transcriptional regulation of the collagenase gene by basic fibroblast factor in osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 214: 331-339, 1995.
22. Kurogi T, Nabeshima K, Kataoka H, Okada Y and Koono, M: Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int J Cancer 66: 82-90, 1996.
23. Kawashima A, Nakanishi I, Tsuchiya H, Roessner A, Obata K and Okada Y: Expression of matrix metalloproteinase 9 (92-kDa gelatinse/type IV collagenase) induced by tumor necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch 424: 547-552, 1994.
24. Bankers-Fulbright JL, Kalli KR and McKean DJ: Interleukin-1 signal transduction. Life Sciences 59: 61-83, 1996.
25. deBart AC, Quax PH, Lowik CW and Verheijen JH: Regulation of plasminogen activation, matrix metalloproteinses and urokinase-type of plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-lalpha. J Bone Mineral Res 10: 1374-1384, 1995.
26. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL and Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion and metastasis 12: 168-184, 1992.
27. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 124: 757-768, 1994
28. 2+/S100 regulation of giant protein kinases. Nature 380: 636-639, 1996.
29. Ford HL, Silver DL, Kachar B, Sellers JR and Zain SB: Effect of Mtsl on the structure and activity of nonmuscle myosin II. Biochemistry 36: 16321-16327, 1997.
30. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990.